insiderdelta

Harpoon Therapeutics, Inc.

HARPCIK 0001708493 · Every Form 4 filed by insiders at this issuer.

Filings

19

Latest Mar 11, 2024

Unique insiders

20

Showing

19 of 19

Page 1

Top insiders

Most active reporters at Harpoon Therapeutics, Inc.

NameRolesFilings
Chin Mark
Director
2
EASTLAND JULIA MARIE
OfficerDirector
2
HUNT RONALD
Director10% Owner
2
Lanza Frank J
Officer
2
Myers Scott Dunseth
Director
2
Walker Luke Nathaniel
Officer
2
BAILES JOSEPH S
Director
1
Bucher James B
Officer
1
DRACHMAN JONATHAN G
Director
1
Lathi Vijay K
Director10% Owner
1

All filings

19 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 11, 2024
Merck & Co., Inc.
10% Owner
P21,397,205$23.00$492,135,715
Mar 11, 2024
Bucher James B
Chief Legal Officer
Holdings only———
Mar 11, 2024
BAILES JOSEPH S
Director
D5,000——
Mar 11, 2024
EASTLAND JULIA MARIE
President and CEO · Director
A31,250$0.00$0
Mar 11, 2024
Lanza Frank J
Principal Fin. & Acctng Ofc.
D18,734——
Mar 11, 2024
Robbins Andrew R
Director
D5,000——
Mar 11, 2024
DRACHMAN JONATHAN G
Director
A415$0.00$0
Mar 11, 2024
Chin Mark
Director
A424$0.00$0
Mar 11, 2024
Myers Scott Dunseth
Director
D22,665——
Mar 11, 2024
Walker Luke Nathaniel
Chief Medical Officer
D135,000——
Mar 11, 2024
HUNT RONALD
Director · 10% Owner
A424$0.00$0
Mar 11, 2024
SILVERNAIL LAUREN P
Director
D5,000——
Mar 11, 2024
New Leaf Biopharma Opportunities II, L.P.
Director · 10% Owner
D1,463,386——
Jan 9, 2024
EASTLAND JULIA MARIE
President and CEO · Director
A178,500$0.00$0
Jan 9, 2024
Lanza Frank J
Principal Fin. & Acctng Ofc.
A15,000$0.00$0
Jan 9, 2024
Walker Luke Nathaniel
Chief Medical Officer
A115,000$0.00$0
Jan 3, 2024
Chin Mark
Director
A1,072$0.00$0
Jan 3, 2024
HUNT RONALD
Director · 10% Owner
A1,072$0.00$0
Jan 3, 2024
Myers Scott Dunseth
Director
A2,048$0.00$0

Showing 1–19 of 19

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.